Paraproteinemia in a child with leukemia.
D000361:Agammaglobulinemia / Q000150:complications; D001796:Blood Protein Disorders / Q000150:complications*; D001797:Blood Protein Electrophoresis; D001856:Bone Marrow Examination; D002675:Child, Preschool; D002848:Chromatography, DEAE-Cellulose; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004586:Electrophoresis; D005782:Gels; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D037102:Lectins; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013213:Starch; D014461:Ultracentrifugation; D014750:Vincristine / Q000627:therapeutic use
D005782:Gels; D007074:Immunoglobulin G; D037102:Lectins; D014750:Vincristine; D003520:Cyclophosphamide; D013213:Starch; D003165:Complement System Proteins; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin